Illegal Activity
none
Blackmail
none
Date
2017-10-10
Document Type
email
Model
gemini-2.0-flash-001
Processed
2026-02-07T18:41
Summary
This email provides the cost basis for securities transferred from Richard Kahn, including A§FehPRVIEIP@R&ip Inc., Foundation Medicine Inc, and Sangamo Therapeutics Inc. Paul Barrett is following up with Richard Kahn to address any questions regarding the cost basis of these assets.
Metadata
- Subject
- Re: Cost Basis
- Sender
- BiaaarsUialui
- Recipients
- Paul Barrett
- Document ID
- EFTA01268400
- Date
- 2017-10-10
Relationships 2
| Entity 1 | Relationship | Entity 2 | Description |
|---|---|---|---|
| BiaaarsUialui | correspondence | Paul Barrett | Email communication regarding cost basis of securities. |
| Richard Kahn | client/advisor | Paul Barrett | Paul Barrett is following up with Richard Kahn regarding cost basis of transferred assets. |
Notable Quotes 2
Cost basis of securities transferred in are as follows:
Hello, Richard. I wanted to follow up with you. My understanding is that there may be some questions around cost basis for the assets that you transferred over. How may I support you?
Financial Information
Amounts:1,500,0001,265,037422,214
Assets:
- A§FehPRVIEIP@R&ip Inc. (Formerly Dress Barn 1.3.11)
- Foundation Medicine Inc
- Sangamo Therapeutics Inc
Transactions:
- Transfer of securities
Raw Analysis JSON
click to expand
Themes
Financial transactions/money flow
People 2
Organizations 3
A§FehPRVIEIP@R&ip Inc. (Formerly Dress Barn 1.3.11)Foundation Medicine IncSangamo Therapeutics Inc
Locations 1
New York NY 10022
Text Analysis
- Tone
- Professional
- Purpose
- To provide cost basis information for securities transferred and to follow up on questions regarding cost basis.
- Significance
- Provides financial details regarding transferred securities and indicates a potential issue or question regarding cost basis.
File Info
- File Name
- EFTA01268400.txt
- Dataset
- dataset_10
- Type
- Text
- Model
- gemini-2.0-flash-001
- Processed
- 2026-02-07T18:41:06.679172
- DOJ Source
- View on DOJ